Clinical trial
A Study To Assess The Pharmacokinetics Of Different Modified Release…
NCT00449709 · GlaxoSmithKline, Industry · Terminated
Key facts
| NCT number | NCT00449709 |
|---|---|
| Title | A Study To Assess The Pharmacokinetics Of Different Modified Release Formulations Of GSK221149 In Healthy Adult Subjects |
| Official title | A Two-part, Open-label, Cross-over Study to Assess the Pharmacokinetics of GSK221149 Following Single Oral Doses of Various Modified Release Formulations and a Solution in Healthy Adult Subjects |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Obstetric Labour, Premature, Premature Ejaculation |
| Intervention type | Drug |
| Interventions | GSK221149 |
| Enrollment | 36 |
| Start date | Mar 1, 2007 |
| First posted | Mar 21, 2007 |
| Last update posted | Mar 19, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: